Undifferentiated Stromal Sarcoma

An infiltrating high grade mesenchymal tumor arising from the uterine corpus, cervix, vagina, and the ovary.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1993-2017
02419932017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Endometrial stromal sarcoma (ESS) is a rare malignant neoplasm of the uterus. We report the first case of undifferentiated ESS… (More)
  • figure 1
  • figure 3
  • figure 2
  • figure 4
Is this relevant?
Review
2014
Review
2014
Endometrial stromal sarcoma (ESS) and undifferentiated endometrial sarcoma (UES) are very rare gynecologic malignancies. Due to… (More)
Is this relevant?
2013
2013
Uterine leiomyosarcoma (LMS) and undifferentiated endometrial sarcoma (UES) are rare, aggressive malignancies. Both are treated… (More)
  • table 1
  • table 2
  • table 3
  • table 3
Is this relevant?
2011
2011
We reported an extremely rare case of undifferentiated endometrial stromal sarcoma imaged with gallium-67 scintigraphy. This… (More)
Is this relevant?
2011
2011
Sir: Tumors of fibroblastic reticular cells (TFBRs) are very uncommon neoplasms whereof less than 20 cases have been described (1… (More)
  • figure 1
  • table 1
  • table 1
Is this relevant?
Review
2008
Review
2008
Endometrial stromal sarcoma (ESS) is a relatively rare uterine sarcoma, especially extrauterine ESS. Furthermore, retroperitoneal… (More)
  • figure 1
  • figure 2
  • table 1
Is this relevant?
2005
2005
OBJECTIVE Endometrial stromal sarcomas (ESS) are very rare neoplasms constituting less than 0.5% of all malignant uterine tumors… (More)
Is this relevant?
1999
1999
AIM To investigate the expression of matrix metalloproteinases (MMP), a group of proteolytic enzymes with a central role in… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
1993
1993
Only 0.2-1% of all mammary malignancies are sarcomas of the breast. This study includes 4 cases: 2 osteosarcomas, 1 fibrosarcoma… (More)
Is this relevant?